Alembic gets FDA OK for generic OluxClobetasol propionate foam is indicated for the treatment of moderate to severe plaque psoriasis of the scalp and mild to moderate plaque psoriasis of non-scalp regions of the body. Alembic intros generic SaphrisThe medication is indicated for bipolar disorder and acute monotherapy of manic or mixed episodes, in pediatric patients aged 10 to 17 years old. Nexus rolls out generic Erythrocin Erythromycin lactobionate for injection is indicated in the treatment of infections caused by susceptible strains of designated organisms when oral administration is not possible. Breckenridge obtains FDA OK for generic Zavesca Zavesca is used to treat adults with mild to moderate Type 1 Gaucher disease. Hikma acquires Custopharm The acquisition complements Hikma’s product portfolio and pipeline, adding up to 13 approved products and additional pipeline products. Long Grove Pharmaceuticals to intro generics products Long Grove Pharmaceuticals said it expects to innovate across the generic injectables, dermatological and topical markets. FDA gives Lupin approval, tentative OK for 2 generics The FDA gave Lupin approval for desvenlafaxine extended-release tablets and tentative approval for tenofovir alafenamide tablets. Sandoz debuts generic Combigan Generic Combigan is used to lower eye pressure in patients with ocular hypertension, or high eye pressure. Amneal obtains FDA nod for Avastin biosimilar The product, which will be marketed under the proprietary name Alymsys, represents the third bevacizumab biosimilar approval. Alembic rolls out generic Emla cream Lidocaine and prilocaine cream is indicated as a topical anesthetic for use on normal intact skin for local analgesia. First Previous 87 88 89 90 91 Next Last
